Bone Grafts And Substitutes Market Analysis and Forecast to 2031: By Product (Allografts, Bone Grafts Substitutes, and Cell Based Matrices), Application (Spinal Fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting), and Region

A bone graft is a surgical procedure that replaces missing bone in order to repair bone fractures that are not able to heal properly on their own. The bone graft may be taken from another area of the patient’s body, or it may be a synthetic or natural bone substitute.

Bone grafting is often necessary in order to provide the necessary support for artificial joints, such as hip replacements. It can also be used to repair damage caused by trauma, congenital defects, or disease. There are a variety of different types of bone grafts and substitutes available, each with its own advantages and disadvantages. The type of graft used will depend on the specific needs of the patient.

Key Trends

Spine fusion surgery has emerged as one of the most widely performed surgeries across the world due to which, the demand for autograft and allograft has witnessed consistent growth. This trend is expected to continue during the forecast period and most likely accelerate the growth of the global bone graft substitutes market.

While the demand for bone graft substitutes for spinal fusion is expected to grow around the world, researchers and medical experts are increasingly focusing on exploring potential applications of bone graft substitutes in the field of regenerative medicine.

Key Drivers

The key drivers of the bone grafts and substitutes market are the rising incidence of orthopedic disorders and the growing number of trauma cases.

The increasing number of sports injuries is also driving the growth of the market. The development of new and improved products is another key driver of the market.

The rising awareness of the benefits of bone grafts and substitutes is also driving the growth of the market.

Restraints & Challenges

The key restraints and challenges in the bone grafts and substitutes market include the high cost of bone grafts and substitutes, the lack of insurance coverage, and the stringent regulations.

The high cost of bone grafts and substitutes is a major restraint for the growth of the market. The cost of bone grafts and substitutes is high due to the expensive raw materials used in the manufacturing of these products. In addition, the cost of surgery and post-operative care is also high. This is a major challenge for the growth of the market.

The lack of insurance coverage is another challenge for the growth of the market. Bone grafts and substitutes are not covered by insurance companies in many countries. This is a major challenge for the growth of the market.

The stringent regulations are another challenge for the growth of the market. The bone grafts and substitutes market is regulated by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These agencies have strict guidelines for the approval of new products. This is a major challenge for the growth of the market.

Market Segments

The Bone Grafts and Substitutes Market is segmented by product, application and region. By product, the bone grafts and substitutes market can be categorized into allografts, bone grafts substitute and cell-based matrices. By application, the bone grafts and substitutes market is segmented into spinal fusion, trauma, craniomaxillofacial, joint reconstruction and dental bone grafting. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Bone Grafts and Substitutes Market includes players such as Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Corporation, Johnson & Johnson, Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Corporation, Xtant Medical Holdings Inc. and Zimmer Biomet Holdings, Inc.

Why GIS?

 

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Bone Grafts And Substitutes Market Outlook
3.1. Bone Grafts And Substitutes Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Bone Grafts And Substitutes Market

Chapter 4. Economic Impact of COVID-19 on Bone Grafts And Substitutes Market
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Bone Grafts And Substitutes Market
4.3. Economic Impact Analysis

Chapter 5. Bone Grafts And Substitutes Market by Product
5.1. Market Overview
5.2. Allografts
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Bone Grafts Substitutes
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Cell based matrices
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Bone Grafts And Substitutes Market by Application
6.1. Market Overview
6.2. Spinal fusion
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Trauma
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Craniomaxillofacial
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Joint reconstruction
6.5.1. Market Size and Forecast, 2021-2031 ($Million)
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.6. Dental bone grafting
6.6.1. Market Size and Forecast, 2021-2031 ($Million)
6.6.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Bone Grafts And Substitutes Market, by Region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.2.3. North America Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.4. North America Bone Grafts And Substitutes Market Size and Forecast by Country, 2021-2031, ($Million)
7.2.5. The U.S.
7.2.5.1. The U.S. Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.2.5.2. The U.S. Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.6. Canada
7.2.6.1. Canada Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.2.6.2. Canada Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.2.7. Mexico
7.2.7.1. Mexico Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.2.7.2. Mexico Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.3. Europe Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.4. Europe Bone Grafts And Substitutes Market Size and Forecast by Country, 2021-2031, ($Million)
7.3.5. Germany
7.3.5.1. Germany Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.5.2. Germany Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.6. France
7.3.6.1. France Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.6.2. France Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.7. U.K.
7.3.7.1. U.K. Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.7.2. U.K. Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.8. Spain
7.3.8.1. Spain Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.8.2. Spain Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.9. Italy
7.3.9.1. Italy Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.9.2. Italy Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.3.10. Rest of Europe
7.3.10.1. Rest of Europe Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.3.10.2. Rest of Europe Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Bone Grafts And Substitutes Market Size and Forecast by Country, 2021-2031, ($Million)
7.4.3. Asia-Pacific Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.4. Asia-Pacific Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.5. China
7.4.5.1. China Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.5.2. China Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.6. India
7.4.6.1. India Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.6.2. India Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.7. Japan
7.4.7.1. Japan Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.7.2. Japan Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.8. South Korea
7.4.8.1. South Korea Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.8.2. South Korea Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.4.9. Rest of APAC
7.4.9.1. Rest of APAC Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.4.9.2. Rest of APAC Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends and Opportunities
7.5.2. Rest of the World Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.5.3. Rest of the World Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.4. Rest of the World Bone Grafts And Substitutes Market Size and Forecast by Country, 2021-2031, ($Million)
7.5.5. Latin America
7.5.5.1. Latin America Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.5.5.2. Latin America Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.6. Middle East
7.5.6.1. Middle East Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.5.6.2. Middle East Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)
7.5.7. Africa
7.5.7.1. Africa Bone Grafts And Substitutes Market Size and Forecast by Product , 2021-2031, ($Million)
7.5.7.2. Africa Bone Grafts And Substitutes Market Size and Forecast by Application, 2021-2031, ($Million)

Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Developmental Strategy Benchmarking
8.3.1. New Product Development
8.3.2. Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Joint Ventures, and Collaborations
8.3.5. Mergers and Acquisitions

Chapter 9. Company Profiles
9.1. Arthrex Inc.
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. Baxter International Inc.
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Integra Life Sciences Holdings Corporation
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. Johnson & Johnson (DePuy Synthes)
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. Medtronic Plc.
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. Musculoskeletal Transplant Foundation
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. NuVasive Inc.
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Stryker Corporation
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. Xtant Medical Holdings Inc.
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. Zimmer Biomet Holdings, Inc.
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

 

Key Players
  • Arthrex Inc.
  • Baxter International Inc.
  • Integra Life Sciences Holdings Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic Plc.
  • Musculoskeletal Transplant Foundation
  • NuVasive Inc.
  • Stryker Corporation
  • Xtant Medical Holdings Inc.
  • Zimmer Biomet Holdings, Inc.
Market Segments

By Product

  • Allografts
  • Bone Grafts Substitutes
  • Cell-based Matrices

By Application

  • Spinal Fusion
  • Trauma
  • Craniomaxillofacial
  • Joint Reconstruction
  • Dental Bone Grafting

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Patient Access Solutions (PAS) is a healthcare technology…
Orthodontics is defined as the branch of dentistry,…
The global HPV testing & PAP test market…
The global Pedicle Screw Systems Market was valued…
The global Isothermal Nucleic Acid Amplification Technology (INAAT)…
The global flexible endoscopes market was valued at…
A clinical trial management system (CTMS) is a…
Health insurance is insurance that covers the whole…
Sexually transmitted disease testing is a process in…
A bone void filler is a material that…